Spinal cord injury: a study protocol for a systematic review and meta-analysis of microRNA alterations.
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
05 04 2022
05 04 2022
Historique:
received:
25
01
2021
accepted:
03
03
2022
entrez:
6
4
2022
pubmed:
7
4
2022
medline:
8
4
2022
Statut:
epublish
Résumé
Spinal cord injury (SCI) is a devastating condition with no current neurorestorative treatments. Clinical trials have been hampered by a lack of meaningful diagnostic and prognostic markers of injury severity and neurologic recovery. Objective biomarkers and novel therapies for SCI represent urgent unmet clinical needs. Biomarkers of SCI that objectively stratify the severity of cord damage could expand the depth and scope of clinical trials and represent targets for the development of novel therapies for acute SCI. MicroRNAs (miRNAs) represent promising candidates both as informative molecules of injury severity and recovery, and as therapeutic targets. miRNAs are small, regulatory RNA molecules that are tissue-specific and evolutionarily conserved across species. miRNAs have been shown to represent powerful predictors of pathology, particularly with respect to neurologic disorders. Studies investigating miRNA alterations in all species of animal models and human studies of acute, traumatic SCI will be identified from PubMed, Embase, and Scopus. We aim to identify whether SCI is associated with a specific pattern of miRNA expression that is conserved across species, and whether SCI is associated with a tissue- or cell type-specific pattern of miRNA expression. The inclusion criteria for this study will include (1) studies published anytime, (2) including all species, and sexes with acute, traumatic SCI, (3) relating to the alteration of miRNA after SCI, using molecular-based detection platforms including qRT-PCR, microarray, and RNA-sequencing, (4) including statistically significant miRNA alterations in tissues, such as spinal cord, serum/plasma, and/or CSF, and (5) studies with a SHAM surgery group. Articles included in the review will have their titles, abstracts, and full texts reviewed by two independent authors. Random effects meta-regression will be performed, which allows for within-study and between-study variability, on the miRNA expression after SCI or SHAM surgery. We will analyze both the cumulative pooled dataset, as well as datasets stratified by species, tissue type, and timepoint to identify miRNA alterations that are specifically related to the injured spinal cord. We aim to identify SCI-related miRNA that are specifically altered both within a species, and those that are evolutionarily conserved across species, including humans. The analyses will provide a description of the evolutionarily conserved miRNA signature of the pathophysiological response to SCI. Here, we present a protocol to perform a systematic review and meta-analysis to investigate the conserved inter- and intra-species miRNA changes that occur due to acute, traumatic SCI. This review seeks to serve as a valuable resource for the SCI community by establishing a rigorous and unbiased description of miRNA changes after SCI for the next generation of SCI biomarkers and therapeutic interventions. The protocol for the systematic review and meta-analysis has been registered through PROSPERO: CRD42021222552 .
Sections du résumé
BACKGROUND
Spinal cord injury (SCI) is a devastating condition with no current neurorestorative treatments. Clinical trials have been hampered by a lack of meaningful diagnostic and prognostic markers of injury severity and neurologic recovery. Objective biomarkers and novel therapies for SCI represent urgent unmet clinical needs. Biomarkers of SCI that objectively stratify the severity of cord damage could expand the depth and scope of clinical trials and represent targets for the development of novel therapies for acute SCI. MicroRNAs (miRNAs) represent promising candidates both as informative molecules of injury severity and recovery, and as therapeutic targets. miRNAs are small, regulatory RNA molecules that are tissue-specific and evolutionarily conserved across species. miRNAs have been shown to represent powerful predictors of pathology, particularly with respect to neurologic disorders.
METHODS
Studies investigating miRNA alterations in all species of animal models and human studies of acute, traumatic SCI will be identified from PubMed, Embase, and Scopus. We aim to identify whether SCI is associated with a specific pattern of miRNA expression that is conserved across species, and whether SCI is associated with a tissue- or cell type-specific pattern of miRNA expression. The inclusion criteria for this study will include (1) studies published anytime, (2) including all species, and sexes with acute, traumatic SCI, (3) relating to the alteration of miRNA after SCI, using molecular-based detection platforms including qRT-PCR, microarray, and RNA-sequencing, (4) including statistically significant miRNA alterations in tissues, such as spinal cord, serum/plasma, and/or CSF, and (5) studies with a SHAM surgery group. Articles included in the review will have their titles, abstracts, and full texts reviewed by two independent authors. Random effects meta-regression will be performed, which allows for within-study and between-study variability, on the miRNA expression after SCI or SHAM surgery. We will analyze both the cumulative pooled dataset, as well as datasets stratified by species, tissue type, and timepoint to identify miRNA alterations that are specifically related to the injured spinal cord. We aim to identify SCI-related miRNA that are specifically altered both within a species, and those that are evolutionarily conserved across species, including humans. The analyses will provide a description of the evolutionarily conserved miRNA signature of the pathophysiological response to SCI.
DISCUSSION
Here, we present a protocol to perform a systematic review and meta-analysis to investigate the conserved inter- and intra-species miRNA changes that occur due to acute, traumatic SCI. This review seeks to serve as a valuable resource for the SCI community by establishing a rigorous and unbiased description of miRNA changes after SCI for the next generation of SCI biomarkers and therapeutic interventions.
TRIAL REGISTRATION
The protocol for the systematic review and meta-analysis has been registered through PROSPERO: CRD42021222552 .
Identifiants
pubmed: 35382886
doi: 10.1186/s13643-022-01921-8
pii: 10.1186/s13643-022-01921-8
pmc: PMC8985297
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
61Informations de copyright
© 2022. The Author(s).
Références
J Neurotrauma. 2019 Mar 19;36(6):845-852
pubmed: 30122113
Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):29113-29122
pubmed: 33139574
J Neurosci. 2012 Dec 12;32(50):17935-47
pubmed: 23238710
Genome Biol. 2004;5(9):R68
pubmed: 15345052
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Clin Chem. 2009 Nov;55(11):1977-83
pubmed: 19745058
BMC Med Res Methodol. 2014 Mar 26;14:43
pubmed: 24667063
JAMA. 1997 May 28;277(20):1597-604
pubmed: 9168289
Eur J Neurosci. 2005 Mar;21(6):1469-77
pubmed: 15845075
Genome Biol. 2004;5(3):R13
pubmed: 15003116
Physiol Genomics. 2011 May 1;43(10):571-80
pubmed: 21385946
Mol Cell Proteomics. 2021;20:100096
pubmed: 34129941
Genome Biol. 2015 Dec 22;16:287
pubmed: 26694591
Sci Rep. 2017 May 3;7(1):1376
pubmed: 28469141
Exp Neurol. 2009 Oct;219(2):424-9
pubmed: 19576215
Front Mol Neurosci. 2013 Nov 26;6:39
pubmed: 24324397
Stroke. 2004 May;35(5):1203-8
pubmed: 15060322
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Behav Modif. 2017 Mar;41(2):323-339
pubmed: 27760807
Cells. 2020 Jan 09;9(1):
pubmed: 31936634
J Neurosci. 2008 Nov 5;28(45):11720-30
pubmed: 18987208
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8
pubmed: 21383194
Aliment Pharmacol Ther. 2016 Jan;43(1):102-13
pubmed: 26503793
Trends Neurosci. 2003 Oct;26(10):555-63
pubmed: 14522149
Nat Rev Neurol. 2013 Jun;9(6):328-39
pubmed: 23588363
Elife. 2018 Oct 02;7:
pubmed: 30277459
Nat Rev Neurosci. 2006 Dec;7(12):911-20
pubmed: 17115073
Global Spine J. 2017 Sep;7(3 Suppl):116S-137S
pubmed: 29164020
N Engl J Med. 1990 May 17;322(20):1405-11
pubmed: 2278545
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):360-5
pubmed: 14691248
RNA. 2003 Oct;9(10):1274-81
pubmed: 13130141
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S87-98
pubmed: 11805614
Paraplegia. 1988 Apr;26(2):71-82
pubmed: 3045730
Cells. 2020 Jan 23;9(2):
pubmed: 31979244
Exp Neurol. 2008 May;211(1):259-70
pubmed: 18384773
JAMA. 1984 Jan 6;251(1):45-52
pubmed: 6361287
N Engl J Med. 2013 May 2;368(18):1685-94
pubmed: 23534542
J Neurotrauma. 2019 Aug 1;36(15):2358-2371
pubmed: 30827169
Front Cell Neurosci. 2014 Feb 25;8:53
pubmed: 24701199
Genome Res. 2016 Apr;26(4):554-65
pubmed: 26821571
Int J Biol Sci. 2014 Sep 06;10(9):997-1006
pubmed: 25210498
Nucleic Acids Res. 2011 Sep 1;39(16):7223-33
pubmed: 21609964
RNA. 2008 Mar;14(3):432-44
pubmed: 18230762